Research advances in antiviral therapy of HBV-associated glomerulonephritis
XIAO Yin-zong
HUANG Yan
ZHOU Qiao-ling
FAN Xue-gong
Abstract：HBV-associated glomerulonephritis (HBV-GN) is one of the most common extrahepatic manifestations of HBV chronic infection and is usually manifested in the form of immune complex-mediated nephropathy. This patient population presents particular features and complicated conditions, requiring specific antiviral therapy, therefore, a timely recognition of treatment timing and correct selection of antiviral agents are critical in managing patients with HBV-GN, but there is not a standardized guideline so far. Based on the latest information, this review focuses on the research progress of antiviral therapy of HBV-GN, and the therapeu-tic efficacy and safety of various antiviral agents, in hope of providing reference for clinical practice.
Keywords：hepatitis B virusglomerulonephritisantiviral agents
Publication Date：2014-01-01
Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)
Pages：5( 240-244 )